Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidPSA

Recognising and responding to adverse drug reactions

Essential points for quick revision.

Saved on this device

Synopsis

Recognise medicine-related harm, assess severity and causality, treat urgent reactions and communicate accurate adverse-reaction information to prevent recurrence.

  • Assess and treat the patient before completing a causality score or reporting form. The next action is determined by physiological severity as well as the suspected mechanism.
  • For adult anaphylaxis, give adrenaline 500 micrograms intramuscularly into the anterolateral thigh, using 0.5 mL of 1 mg/mL solution; repeat after 5 minutes if airway, breathing or circulation problems persist.
  • Stop the suspected infusion or exposure when feasible, call for help and use an ABCDE approach. Antihistamines and corticosteroids do not replace adrenaline for life-threatening anaphylaxis.

Key red flags

Airway swelling, breathing difficulty or circulatory compromise after medicine exposure requires immediate emergency assessment and treatment for possible anaphylaxis.

Fever with a painful widespread rash, blistering, mucosal involvement or systemic organ symptoms after a new medicine needs urgent assessment for a severe delayed reaction.

Reasoning priorities

01
Immediate observations and targeted bedside tests

Assess severity and identify threats requiring treatment now.

Use airway assessment, respiratory observations, pulse, pressure, consciousness and other indicated bedside tests. Do not wait for a laboratory result to treat anaphylaxis. In a suspected pharmacological reaction, glucose or ECG assessment may rapidly identify the mechanism of collapse or confusion.

Worked reasoning

Worked exampleTreat an immediate severe antibiotic reaction

A 42-year-old receiving an IV co-amoxiclav dose develops widespread urticaria, wheeze and throat tightness within minutes. Blood pressure is 78/46 mmHg and oxygen saturation 90%. Adrenaline 1 mg/mL is available, and no adrenaline has yet been given.

  1. Recognise airway/breathing and circulatory compromise consistent with anaphylaxis. Stop the suspected infusion, call the emergency team and assess ABCDE. Position safely, usually lying flat with legs raised if tolerated; adapt for breathing difficulty and do not allow sudden standing.
  2. Calculate the intramuscular adrenaline volume: 500 micrograms equals 0.5 mg; 0.5 mg divided by 1 mg/mL equals 0.5 mL. Administer 500 micrograms IM into the anterolateral thigh promptly, alongside oxygen and the required resuscitation support.
  3. Reassess airway, breathing and circulation and repeat the IM dose after 5 minutes if problems persist. Obtain senior help, IV access and further anaphylaxis-pathway treatment as needed; antihistamines are not the first treatment for this hypotensive wheezing patient.
  4. Give the final immediate action as IM adrenaline and continuing emergency reassessment. Independently check the ampoule concentration, microgram-to-milligram conversion and 0.5 mL volume, then record administration time and response. After stabilisation, arrange observation, reaction documentation, indicated tests and specialist follow-up.
Causality assessmentInvestigate a possible non-emergency adverse effect

A stable patient reports a new symptom after a medicine or regimen change.

Key medicines

Adrenaline for adult anaphylaxis500 micrograms intramuscularly in the anterolateral thigh, equivalent to 0.5 mL of 1 mg/mL solution; repeat after 5 minutes if airway, breathing or circulation problems persist.Check concentration and route carefully. IV adrenaline requires experienced specialist management and is not the routine initial route. Pregnancy does not justify withholding indicated IM treatment; positioning and further resuscitation require the clinical context.
Open full textbook Answer 2 questions
Sources and review status6 sources · checked 7 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom